aspirin has been researched along with oseltamivir in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Barrett, J; Dorr, A; Liu, B; Oo, C; Ward, P | 1 |
Gaedigk, R; Pearce, RE; Wan, YJ; Wang, X; Yan, B; Yang, D | 1 |
Malmioja, K; Peura, L; Rautio, J | 1 |
Merali, Z; Paré, G; Ross, S | 1 |
Hu, ZY; Laizure, SC; Meibohm, B; Parker, RB | 1 |
Aoi, S; Golfeyz, S; Harrington, M; Kobayashi, T | 1 |
Burov, SV; Haq, S; Harless, W; Markvicheva, E; Qorri, B; Sambi, M; Samuel, V; Szewczuk, MR | 1 |
3 review(s) available for aspirin and oseltamivir
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Prodrug technology in the development of medicinal agents].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aspirin; Clopidogrel; Drug Delivery Systems; Drug Design; Humans; Lansoprazole; Oseltamivir; Prodrugs; Simvastatin; Ticlopidine | 2011 |
The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Aspirin; Benzimidazoles; Camptothecin; Carboxylesterase; Carboxylic Ester Hydrolases; Central Nervous System Stimulants; Clopidogrel; Dabigatran; Factor Xa Inhibitors; Genotype; Humans; Imidazolidines; Irinotecan; Isoenzymes; Methylphenidate; Oseltamivir; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Pyridines; Ticlopidine | 2014 |
2 trial(s) available for aspirin and oseltamivir
Article | Year |
---|---|
Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirin.
Topics: Acetamides; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Aspirin; Cross-Over Studies; Drug Interactions; Female; Hippurates; Humans; Male; Oseltamivir; Prodrugs; Salicylic Acid | 2002 |
Effects of alcohol on human carboxylesterase drug metabolism.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Aspirin; Carboxylesterase; Carboxylic Ester Hydrolases; Cross-Over Studies; Enzyme Inhibitors; Ethanol; Female; Humans; Hydrolysis; Male; Middle Aged; Oseltamivir | 2015 |
6 other study(ies) available for aspirin and oseltamivir
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin.
Topics: Adolescent; Adult; Antiviral Agents; Aspirin; Carboxylesterase; Carboxylic Ester Hydrolases; Child; Child, Preschool; Gene Expression Regulation, Developmental; Gene Expression Regulation, Enzymologic; Genetic Variation; Humans; Hydrolysis; Infant; Infant, Newborn; Kinetics; Microsomes, Liver; Nitriles; Oseltamivir; Permethrin; Pyrethrins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Substrate Specificity; Young Adult | 2009 |
Possible association of influenza A infection and reverse takotsubo syndrome.
Topics: Acute Coronary Syndrome; Aged; Antiviral Agents; Aspirin; Atorvastatin; Chest Pain; Coronary Angiography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Influenza A virus; Influenza, Human; Oseltamivir; Platelet Aggregation Inhibitors; Takotsubo Cardiomyopathy; Treatment Outcome | 2018 |
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Apoptosis; Aspirin; Breast Neoplasms; CD24 Antigen; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Hyaluronan Receptors; Metformin; Oseltamivir; Retinal Dehydrogenase; Spheroids, Cellular; Tamoxifen; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2020 |